Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

MLA

Meriem Bekliz, et al. “Neutralization Capacity of Antibodies Elicited through Homologous or Heterologous Infection or Vaccination against SARS-CoV-2 VOCs.” Nature Communications, vol. 13, no. 1, July 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41467-022-31556-1.

APA

Meriem Bekliz, Kenneth Adea, Pauline Vetter, Christiane S. Eberhardt, Krisztina Hosszu-Fellous, Diem-Lan Vu, Olha Puhach, Manel Essaidi-Laziosi, Sophie Waldvogel-Abramowski, Caroline Stephan, Arnaud G. L’Huillier, Claire-Anne Siegrist, Arnaud M. Didierlaurent, Laurent Kaiser, Benjamin Meyer, & Isabella Eckerle. (2022). Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs. Nature Communications, 13(1), 1–10. https://doi.org/10.1038/s41467-022-31556-1

Chicago

Meriem Bekliz, Kenneth Adea, Pauline Vetter, Christiane S. Eberhardt, Krisztina Hosszu-Fellous, Diem-Lan Vu, Olha Puhach, et al. 2022. “Neutralization Capacity of Antibodies Elicited through Homologous or Heterologous Infection or Vaccination against SARS-CoV-2 VOCs.” Nature Communications 13 (1): 1–10. doi:10.1038/s41467-022-31556-1.